Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 147

1.

Adverse Events Associated With Infusion of Hematopoietic Stem Cell Products: A Prospective and Multicenter Surveillance Study.

Ikeda K, Ohto H, Okuyama Y, Yamada-Fujiwara M, Kanamori H, Fujiwara SI, Muroi K, Mori T, Kasama K, Iseki T, Nagamura-Inoue T, Fujii N, Ashida T, Kameda K, Kanda J, Hirose A, Takahashi T, Nagai K, Minakawa K, Tanosaki R.

Transfus Med Rev. 2018 Jun 1. pii: S0887-7963(18)30023-3. doi: 10.1016/j.tmrv.2018.05.005. [Epub ahead of print] Review.

2.

Prognostic importance of pretransplant disease status for posttransplant outcomes in patients with adult T cell leukemia/lymphoma.

Inoue Y, Fuji S, Tanosaki R, Inamoto Y, Tanaka T, Ito A, Okinaka K, Kurosawa S, Kim SW, Nakagama H, Fukuda T.

Bone Marrow Transplant. 2018 Sep;53(9):1105-1115. doi: 10.1038/s41409-018-0139-z. Epub 2018 Mar 9.

PMID:
29523883
3.

Risk Assessment in Adult T Cell Leukemia/Lymphoma Treated with Allogeneic Hematopoietic Stem Cell Transplantation.

Yoshimitsu M, Tanosaki R, Kato K, Ishida T, Choi I, Takatsuka Y, Fukuda T, Eto T, Hidaka M, Uchida N, Miyamoto T, Nakashima Y, Moriuchi Y, Nagafuji K, Miyazaki Y, Ichinohe T, Takanashi M, Atsuta Y, Utsunomiya A; ATL Working Group of the Japan Society for Hematopoietic Cell Transplantation.

Biol Blood Marrow Transplant. 2018 Apr;24(4):832-839. doi: 10.1016/j.bbmt.2017.11.005. Epub 2017 Nov 16.

4.

Therapy-related Acute Myeloid Leukemia after the Long-term Administration of Low-dose Etoposide for Chronic-type Adult T-cell Leukemia-lymphoma: A Case Report and Literature Review.

Shimada N, Ohno N, Tanosaki R, Fuji S, Suzuki Y, Yuji K, Uchimaru K, Tojo A.

Intern Med. 2017;56(14):1879-1884. doi: 10.2169/internalmedicine.56.7763. Epub 2017 Jul 15.

5.

Adult T-cell leukemia cell-induced uveitis: rapid increase in adult T-cell leukemia cells disrupts the blood-ocular barrier.

Hirano M, Ohno N, Tanosaki R, Mochizuki M, Ohno-Matsui K, Uchimaru K, Tojo A, Kamoi K.

Int J Hematol. 2017 Dec;106(6):842-846. doi: 10.1007/s12185-017-2293-2. Epub 2017 Jul 4.

PMID:
28677112
6.

Increased incidence of oral and gastrointestinal secondary cancer after allogeneic hematopoietic stem cell transplantation.

Tanaka Y, Kurosawa S, Tajima K, Tanaka T, Ito R, Inoue Y, Okinaka K, Inamoto Y, Fuji S, Kim SW, Tanosaki R, Yamashita T, Fukuda T.

Bone Marrow Transplant. 2017 May;52(5):789-791. doi: 10.1038/bmt.2017.4. Epub 2017 Feb 13. No abstract available.

PMID:
28194030
7.

Prospective randomized and crossover comparison of two apheresis machines for peripheral blood stem cell collection: a multicenter study.

Ikeda K, Minakawa K, Muroi K, Fujiwara SI, Yamada-Fujiwara M, Fujimori Y, Tanosaki R, Ohto H; Study Group for Peripheral Blood Stem Cell Collection, Cell Therapy Committee, The Japan Society of Transfusion Medicine and Cell Therapy.

Transfusion. 2016 Nov;56(11):2839-2847. doi: 10.1111/trf.13777. Epub 2016 Aug 29.

PMID:
27572290
8.

Clinical Outcomes after Allogeneic Stem Cell Transplantation for Adult Lymphoblastic Lymphoma.

Makita S, Fuji S, Takano K, Tanaka T, Inoue Y, Ito R, Ito A, Hayashi Y, Tajima K, Okinaka K, Kurosawa S, Kim SW, Yamashita T, Tanosaki R, Tobinai K, Fukuda T.

J Clin Exp Hematop. 2016;56(1):28-33. doi: 10.3960/jslrt.56.28.

9.

Association of Cumulative Steroid Dose with Risk of Infection after Treatment for Severe Acute Graft-versus-Host Disease.

Matsumura-Kimoto Y, Inamoto Y, Tajima K, Kawajiri A, Tanaka T, Hirakawa T, Ino K, Asao Y, Tamogami H, Kono C, Takeda W, Okinaka K, Fuji S, Kurosawa S, Kim SW, Tanosaki R, Yamashita T, Fukuda T.

Biol Blood Marrow Transplant. 2016 Jun;22(6):1102-1107. doi: 10.1016/j.bbmt.2016.02.020. Epub 2016 Mar 8.

10.

Eltrombopag for Treatment of Thrombocytopenia after Allogeneic Hematopoietic Cell Transplantation.

Tanaka T, Inamoto Y, Yamashita T, Fuji S, Okinaka K, Kurosawa S, Kim SW, Tanosaki R, Fukuda T.

Biol Blood Marrow Transplant. 2016 May;22(5):919-24. doi: 10.1016/j.bbmt.2016.01.018. Epub 2016 Jan 16.

11.

Analysis of non-relapse mortality and causes of death over 15 years following allogeneic hematopoietic stem cell transplantation.

Tanaka Y, Kurosawa S, Tajima K, Tanaka T, Ito R, Inoue Y, Okinaka K, Inamoto Y, Fuji S, Kim SW, Tanosaki R, Yamashita T, Fukuda T.

Bone Marrow Transplant. 2016 Apr;51(4):553-9. doi: 10.1038/bmt.2015.330. Epub 2016 Jan 11.

PMID:
26752142
12.

Pretransplant mogamulizumab against ATLL might increase the risk of acute GVHD and non-relapse mortality.

Inoue Y, Fuji S, Tanosaki R, Fukuda T.

Bone Marrow Transplant. 2016 May;51(5):725-7. doi: 10.1038/bmt.2015.315. Epub 2015 Dec 21. No abstract available.

PMID:
26691420
13.

Clinical outcomes of a novel therapeutic vaccine with Tax peptide-pulsed dendritic cells for adult T cell leukaemia/lymphoma in a pilot study.

Suehiro Y, Hasegawa A, Iino T, Sasada A, Watanabe N, Matsuoka M, Takamori A, Tanosaki R, Utsunomiya A, Choi I, Fukuda T, Miura O, Takaishi S, Teshima T, Akashi K, Kannagi M, Uike N, Okamura J.

Br J Haematol. 2015 May;169(3):356-67. doi: 10.1111/bjh.13302. Epub 2015 Jan 22.

PMID:
25612920
14.

A case of post-transplant adult T-cell leukemia/lymphoma presenting myelopathy similar to but distinct from human T-cell leukemia virus type I (HTLV- I)-associated myelopathy.

Kawamata T, Ohno N, Sato K, Kobayashi M, Jo N, Yuji K, Tanosaki R, Yamano Y, Tojo A, Uchimaru K.

Springerplus. 2014 Oct 4;3:581. doi: 10.1186/2193-1801-3-581. eCollection 2014.

15.

A higher number of infused CD34(+) cells has a positive impact on the clinical outcome after related PBSC transplantation.

Maie K, Fuji S, Tajima K, Tatsuno M, Yamagata S, Takahashi N, Ueda R, Hashimoto H, Takano K, Inoue Y, Ito A, Hayashi Y, Okinaka K, Kurosawa S, Kim SW, Tanosaki R, Heike Y, Yamashita T, Fukuda T.

Bone Marrow Transplant. 2014 Aug;49(8):1113-5. doi: 10.1038/bmt.2014.94. Epub 2014 May 5. No abstract available.

PMID:
24797181
16.

[Recent therapeutic strategy for hematologic disorders--hematopoietic stem cell transplantation. Overview].

Tanosaki R.

Rinsho Ketsueki. 2014 Feb;55(2):159. Japanese. No abstract available.

PMID:
24598181
17.

Novel and rapid enumeration method of peripheral blood stem cells using automated hematology analyzer.

Tanosaki R, Kumazawa T, Yoshida A, Oguni S, Nakano A, Yamagata S, Takahashi N, Kurosawa S, Kim SW, Yamashita T, Mori S, Heike Y, Fukuda T, Hamaguchi Y, Tsuda H.

Int J Lab Hematol. 2014 Oct;36(5):521-30. doi: 10.1111/ijlh.12182. Epub 2013 Dec 27.

PMID:
24373185
18.

Impact of graft-versus-host disease on allogeneic hematopoietic cell transplantation for adult T cell leukemia-lymphoma focusing on preconditioning regimens: nationwide retrospective study.

Ishida T, Hishizawa M, Kato K, Tanosaki R, Fukuda T, Takatsuka Y, Eto T, Miyazaki Y, Hidaka M, Uike N, Miyamoto T, Tsudo M, Sakamaki H, Morishima Y, Suzuki R, Utsunomiya A.

Biol Blood Marrow Transplant. 2013 Dec;19(12):1731-9. doi: 10.1016/j.bbmt.2013.09.014. Epub 2013 Sep 30.

19.

PBSC collection from family donors in Japan: a prospective survey.

Kodera Y, Yamamoto K, Harada M, Morishima Y, Dohy H, Asano S, Ikeda Y, Nakahata T, Imamura M, Kawa K, Kato S, Tanimoto M, Kanda Y, Tanosaki R, Shiobara S, Kim SW, Nagafuji K, Hino M, Miyamura K, Suzuki R, Hamajima N, Fukushima M, Tamakoshi A; Japan Society for Hematopoietic Cell Transplantation, Halter J, Schmitz N, Niederwieser D, Gratwohl A; European Blood and Marrow Transplant Group.

Bone Marrow Transplant. 2014 Feb;49(2):195-200. doi: 10.1038/bmt.2013.147. Epub 2013 Sep 30.

PMID:
24076552
20.

Potential contribution of a novel Tax epitope-specific CD4+ T cells to graft-versus-Tax effect in adult T cell leukemia patients after allogeneic hematopoietic stem cell transplantation.

Tamai Y, Hasegawa A, Takamori A, Sasada A, Tanosaki R, Choi I, Utsunomiya A, Maeda Y, Yamano Y, Eto T, Koh KR, Nakamae H, Suehiro Y, Kato K, Takemoto S, Okamura J, Uike N, Kannagi M.

J Immunol. 2013 Apr 15;190(8):4382-92. doi: 10.4049/jimmunol.1202971. Epub 2013 Mar 8.

21.

Diagnosis and evaluation of intestinal graft-versus-host disease after allogeneic hematopoietic stem cell transplantation following reduced-intensity and myeloablative conditioning regimens.

Yamasaki S, Miyagi-Maeshima A, Kakugawa Y, Matsuno Y, Ohara-Waki F, Fuji S, Morita-Hoshi Y, Mori M, Kim SW, Mori S, Fukuda T, Tanosaki R, Shimoda T, Tobinai K, Saito D, Takaue Y, Teshima T, Heike Y.

Int J Hematol. 2013 Mar;97(3):421-6. doi: 10.1007/s12185-013-1297-9. Epub 2013 Feb 23.

PMID:
23435651
22.

Dendritic cell-based vaccination in metastatic melanoma patients: phase II clinical trial.

Oshita C, Takikawa M, Kume A, Miyata H, Ashizawa T, Iizuka A, Kiyohara Y, Yoshikawa S, Tanosaki R, Yamazaki N, Yamamoto A, Takesako K, Yamaguchi K, Akiyama Y.

Oncol Rep. 2012 Oct;28(4):1131-8. doi: 10.3892/or.2012.1956. Epub 2012 Aug 7.

23.

Carcinoma of donor origin after allogeneic peripheral blood stem cell transplantation.

Munakata W, Nomoto J, Takahashi N, Taniguchi H, Maeshima AM, Asamura H, Tanosaki R, Heike Y, Fukuda T, Tobinai K, Kobayashi Y.

Am J Surg Pathol. 2012 Sep;36(9):1376-84. doi: 10.1097/PAS.0b013e318261089c.

PMID:
22895271
24.

Allogeneic hematopoietic stem cell transplantation for adult T-cell leukemia-lymphoma with special emphasis on preconditioning regimen: a nationwide retrospective study.

Ishida T, Hishizawa M, Kato K, Tanosaki R, Fukuda T, Taniguchi S, Eto T, Takatsuka Y, Miyazaki Y, Moriuchi Y, Hidaka M, Akashi K, Uike N, Sakamaki H, Morishima Y, Kato K, Suzuki R, Nishiyama T, Utsunomiya A.

Blood. 2012 Aug 23;120(8):1734-41. doi: 10.1182/blood-2012-03-414490. Epub 2012 Jun 11.

25.

Comparison of outcomes after allogeneic hematopoietic stem cell transplantation in patients with follicular lymphoma, diffuse large B-cell lymphoma associated with follicular lymphoma, or de novo diffuse large B-cell lymphoma.

Tada K, Kim SW, Asakura Y, Hiramoto N, Yakushijin K, Kurosawa S, Tajima K, Mori S, Heike Y, Tanosaki R, Maeshima AM, Taniguchi H, Furuta K, Kagami Y, Matsuno Y, Tobinai K, Takaue Y, Fukuda T.

Am J Hematol. 2012 Aug;87(8):770-5. doi: 10.1002/ajh.23246. Epub 2012 May 28.

26.

Stenotrophomonas maltophilia infection in hematopoietic SCT recipients: high mortality due to pulmonary hemorrhage.

Tada K, Kurosawa S, Hiramoto N, Okinaka K, Ueno N, Asakura Y, Kim SW, Yamashita T, Mori SI, Heike Y, Maeshima AM, Tanosaki R, Tobinai K, Fukuda T.

Bone Marrow Transplant. 2013 Jan;48(1):74-9. doi: 10.1038/bmt.2012.87. Epub 2012 May 28.

PMID:
22635245
27.

[Hematopoietic stem cell transplantation for hematologic disorders].

Tanosaki R.

Nihon Rinsho. 2011 Dec;69(12):2172-8. Review. Japanese.

PMID:
22242316
28.

Impact of graft-versus-host disease on outcomes after allogeneic hematopoietic cell transplantation for adult T-cell leukemia: a retrospective cohort study.

Kanda J, Hishizawa M, Utsunomiya A, Taniguchi S, Eto T, Moriuchi Y, Tanosaki R, Kawano F, Miyazaki Y, Masuda M, Nagafuji K, Hara M, Takanashi M, Kai S, Atsuta Y, Suzuki R, Kawase T, Matsuo K, Nagamura-Inoue T, Kato S, Sakamaki H, Morishima Y, Okamura J, Ichinohe T, Uchiyama T.

Blood. 2012 Mar 1;119(9):2141-8. doi: 10.1182/blood-2011-07-368233. Epub 2012 Jan 10.

29.

Bulky disease has an impact on outcomes in primary diffuse large B-cell lymphoma of the breast: a retrospective analysis at a single institution.

Fukuhara S, Watanabe T, Munakata W, Mori M, Maruyama D, Kim SW, Kobayashi Y, Taniguchi H, Maeshima AM, Tanosaki R, Matsuno Y, Tobinai K.

Eur J Haematol. 2011 Nov;87(5):434-40. doi: 10.1111/j.1600-0609.2011.01679.x. Epub 2011 Aug 19.

PMID:
21740461
30.

Adult T-cell leukemia-lymphoma: current treatment strategies and novel immunological approaches.

Tanosaki R, Tobinai K.

Expert Rev Hematol. 2010 Dec;3(6):743-53. doi: 10.1586/ehm.10.73. Review.

PMID:
21091150
31.

Cost and effectiveness of reduced-intensity and conventional allogeneic hematopoietic stem cell transplantation for acute myelogenous leukemia and myelodysplastic syndrome.

Imataki O, Kamioka T, Fukuda T, Tanosaki R, Takaue Y.

Support Care Cancer. 2010 Dec;18(12):1565-9. doi: 10.1007/s00520-009-0779-z. Epub 2009 Nov 22.

PMID:
20967555
32.

Hematopoietic stem cell transplantation for therapy-related myelodysplastic syndrome and acute leukemia: a single-center analysis of 47 patients.

Yokoyama H, Mori S, Kobayashi Y, Kurosawa S, Saito B, Fuji S, Maruyama D, Azuma T, Kim SW, Watanabe T, Tanosaki R, Tobinai K, Takaue Y, Fukuda T.

Int J Hematol. 2010 Sep;92(2):334-41. doi: 10.1007/s12185-010-0640-7. Epub 2010 Aug 4.

PMID:
20680530
33.

Endoscopic diagnosis of cytomegalovirus gastritis after allogeneic hematopoietic stem cell transplantation.

Kakugawa Y, Kami M, Matsuda T, Saito Y, Kim SW, Fukuda T, Mori S, Shimoda T, Tanosaki R, Saito D.

World J Gastroenterol. 2010 Jun 21;16(23):2907-12.

34.

Transplantation of allogeneic hematopoietic stem cells for adult T-cell leukemia: a nationwide retrospective study.

Hishizawa M, Kanda J, Utsunomiya A, Taniguchi S, Eto T, Moriuchi Y, Tanosaki R, Kawano F, Miyazaki Y, Masuda M, Nagafuji K, Hara M, Takanashi M, Kai S, Atsuta Y, Suzuki R, Kawase T, Matsuo K, Nagamura-Inoue T, Kato S, Sakamaki H, Morishima Y, Okamura J, Ichinohe T, Uchiyama T.

Blood. 2010 Aug 26;116(8):1369-76. doi: 10.1182/blood-2009-10-247510. Epub 2010 May 17.

35.

Long-term outcomes after hematopoietic SCT for adult T-cell leukemia/lymphoma: results of prospective trials.

Choi I, Tanosaki R, Uike N, Utsunomiya A, Tomonaga M, Harada M, Yamanaka T, Kannagi M, Okamura J; ATLL allo-HSCT Study Group.

Bone Marrow Transplant. 2011 Jan;46(1):116-8. doi: 10.1038/bmt.2010.92. Epub 2010 Apr 19.

PMID:
20400987
36.

Outcome of 93 patients with relapse or progression following allogeneic hematopoietic cell transplantation.

Kurosawa S, Fukuda T, Tajima K, Saito B, Fuji S, Yokoyama H, Kim SW, Mori S, Tanosaki R, Heike Y, Takaue Y.

Am J Hematol. 2009 Dec;84(12):815-20. doi: 10.1002/ajh.21555.

37.

Decreased insulin secretion in patients receiving tacrolimus as GVHD prophylaxis after allogeneic hematopoietic SCT.

Fuji S, Kim SW, Mori S, Furuta K, Tanosaki R, Heike Y, Takaue Y, Fukuda T.

Bone Marrow Transplant. 2010 Feb;45(2):405-6. doi: 10.1038/bmt.2009.154. Epub 2009 Aug 3. No abstract available.

PMID:
19648969
38.

Intensive glucose control after allogeneic hematopoietic stem cell transplantation: a retrospective matched-cohort study.

Fuji S, Kim SW, Mori S, Kamiya S, Yoshimura K, Yokoyama H, Kurosawa S, Saito B, Takahashi T, Kuwahara S, Heike Y, Tanosaki R, Takaue Y, Fukuda T.

Bone Marrow Transplant. 2009 Jul;44(2):105-11. doi: 10.1038/bmt.2008.431. Epub 2009 Jan 19.

PMID:
19151794
39.

Hematopoietic stem cell transplantation for core binding factor acute myeloid leukemia: t(8;21) and inv(16) represent different clinical outcomes.

Kuwatsuka Y, Miyamura K, Suzuki R, Kasai M, Maruta A, Ogawa H, Tanosaki R, Takahashi S, Koda K, Yago K, Atsuta Y, Yoshida T, Sakamaki H, Kodera Y.

Blood. 2009 Feb 26;113(9):2096-103. doi: 10.1182/blood-2008-03-145862. Epub 2009 Jan 6.

40.

Busulfex (i.v. BU) and CY regimen before SCT: Japanese-targeted phase II pharmacokinetics combined study.

Kim SW, Mori SI, Tanosaki R, Fukuda T, Kami M, Sakamaki H, Yamashita T, Kodera Y, Terakura S, Taniguchi S, Miyakoshi S, Usui N, Yano S, Kawano Y, Nagatoshi Y, Harada M, Morishima Y, Okamoto S, Saito AM, Ohashi Y, Ueda R, Takaue Y.

Bone Marrow Transplant. 2009 Apr;43(8):611-7. doi: 10.1038/bmt.2008.372. Epub 2008 Nov 17.

PMID:
19011665
41.

Impact of T cell chimerism on clinical outcome in 117 patients who underwent allogeneic stem cell transplantation with a busulfan-containing reduced-intensity conditioning regimen.

Saito B, Fukuda T, Yokoyama H, Kurosawa S, Takahashi T, Fuji S, Takahashi N, Tajima K, Kim SW, Mori SI, Tanosaki R, Takaue Y, Heike Y.

Biol Blood Marrow Transplant. 2008 Oct;14(10):1148-1155. doi: 10.1016/j.bbmt.2008.07.013.

42.

Allogeneic hematopoietic stem cell transplantation using reduced-intensity conditioning for adult T cell leukemia/lymphoma: impact of antithymocyte globulin on clinical outcome.

Tanosaki R, Uike N, Utsunomiya A, Saburi Y, Masuda M, Tomonaga M, Eto T, Hidaka M, Harada M, Choi I, Yamanaka T, Kannagi M, Matsuoka M, Okamura J.

Biol Blood Marrow Transplant. 2008 Jun;14(6):702-8. doi: 10.1016/j.bbmt.2008.03.010.

43.

Characterization of acute graft-versus-host disease following reduced-intensity stem-cell transplantation from an HLA-identical related donor.

Murashige N, Kami M, Mori S, Katayama Y, Kobayashi K, Onishi Y, Hori A, Kishi Y, Hamaki T, Tajima K, Kanda Y, Tanosaki R, Takaue Y.

Am J Hematol. 2008 Aug;83(8):630-4. doi: 10.1002/ajh.21197.

44.

Preengraftment serum C-reactive protein (CRP) value may predict acute graft-versus-host disease and nonrelapse mortality after allogeneic hematopoietic stem cell transplantation.

Fuji S, Kim SW, Fukuda T, Mori S, Yamasaki S, Morita-Hoshi Y, Ohara-Waki F, Heike Y, Tobinai K, Tanosaki R, Takaue Y.

Biol Blood Marrow Transplant. 2008 May;14(5):510-7. doi: 10.1016/j.bbmt.2008.02.008.

45.

Infectious complications in chronic graft-versus-host disease: a retrospective study of 145 recipients of allogeneic hematopoietic stem cell transplantation with reduced- and conventional-intensity conditioning regimens.

Yamasaki S, Heike Y, Mori S, Fukuda T, Maruyama D, Kato R, Usui E, Koido K, Kim S, Tanosaki R, Tobinai K, Teshima T, Takaue Y.

Transpl Infect Dis. 2008 Jul;10(4):252-9. doi: 10.1111/j.1399-3062.2007.00291.x. Epub 2008 Jan 9.

PMID:
18194371
46.

Functional analysis of cytomegalovirus-specific T lymphocytes compared to tetramer assay in patients undergoing hematopoietic stem cell transplantation.

Morita-Hoshi Y, Heike Y, Kawakami M, Sugita T, Miura O, Kim SW, Mori SI, Fukuda T, Tanosaki R, Tobinai K, Takaue Y.

Bone Marrow Transplant. 2008 Mar;41(6):515-21. Epub 2007 Nov 19.

PMID:
18026143
47.

Hyperglycemia during the neutropenic period is associated with a poor outcome in patients undergoing myeloablative allogeneic hematopoietic stem cell transplantation.

Fuji S, Kim SW, Mori S, Fukuda T, Kamiya S, Yamasaki S, Morita-Hoshi Y, Ohara-Waki F, Honda O, Kuwahara S, Tanosaki R, Heike Y, Tobinai K, Takaue Y.

Transplantation. 2007 Oct 15;84(7):814-20.

PMID:
17984832
48.

Allogeneic stem cell transplantation for adult T-cell leukemia/lymphoma.

Okamura J, Uike N, Utsunomiya A, Tanosaki R.

Int J Hematol. 2007 Aug;86(2):118-25. Review.

PMID:
17875524
49.

T-cell large granular lymphocyte leukemia of donor origin after cord blood transplantation.

Kusumoto S, Mori S, Nosaka K, Morita-Hoshi Y, Onishi Y, Kim SW, Watanabe T, Heike Y, Tanosaki R, Takaue Y, Tobinai K.

Clin Lymphoma Myeloma. 2007 Jul;7(7):475-9.

PMID:
17875238
50.

Development of solitary plasmacytoma in the internal auditory canal and inner ear after allogeneic hematopoietic stem cell transplantation for plasma cell leukemia.

Masuda M, Inoue Y, Tanosaki R, Kanzaki S, Ogawa K.

Jpn J Clin Oncol. 2007 Sep;37(9):701-3. Epub 2007 Aug 2.

PMID:
17673474

Supplemental Content

Loading ...
Support Center